Skip to main content
Search hero banner

Search results

Showing 1 - 20 of 171 results

early-careers-programs

Early Career Programs

ANSTO’s vision is to deliver excellence in innovation, insight and discovery through our people, partnerships, nuclear expertise and landmark infrastructure. We are committed to investing in our people to achieve this vision.

Enhancing the science of rivets earns researcher early career award

Dr Rezwanul Haque, now a senior lecturer at the University of the Sunshine Coast, received a national Young Scientist Award for his earlier research using nuclear techniques at ANSTO’s Australian Centre for Neutron Scattering to find cracks and signs of stress in riveted joints in sheet metal in car bodies.

Australian Synchrotron Stephen Wilkins Thesis Medal and Early Career Award announced

The 2023 Australian Synchrotron Stephen Wilkins Thesis Medal has been awarded to Dr Yanxiang Meng from the Walter & Eliza Hall Institute for Medical Research and the University of Melbourne for his research investigating the molecular mechanism at work in a form of programmed cell death, which is implicated in a variety of inflammatory diseases.

Diversity and inclusion at ANSTO

Diversity, Equity, Inclusion and Belonging

At ANSTO we understand that diverse teams produce better outcomes – and we value the merit that a diverse perspective can bring to the quality and outcomes of our work, and the way we get the job done.

France city-scape

SAAFE Research Internship Program (2025)

Applications are currently open for the 2024 Scholarship AINSE ANSTO French Embassies (SAAFE) Research Internship Program. The SAAFE Program supports early career researchers at PhD and Postdoctoral level to expand research and innovation activities within Human Health, the Environment and the Nuclear Fuel Cycle, to initiate sustainable research networks and linkages to support Australia, New Zealand and France research and innovation.

Safeguarding the future of nuclear medicine production

The Government is safeguarding Australia’s sovereign capability to produce vital nuclear medicines by launching a $30 million project to design a new world-leading manufacturing facility to be built at Lucas Heights in Sydney.

Pagination